The therapeutic potential of the cognate CXCR4 agonist chemokine (C-X-C motif) ligand 12 (CXCL12, stromal cell-derived factor 1α) during development of ARDS, however, is unknown. This evidence concerns the gene CXCL12 and acute respiratory distress syndrome.